Cognito Therapeutics, Inc. is a biotechnology company based in Newton, MA, focused on developing innovative therapies for neurodegenerative diseases, particularly Alzheimer's disease. The company specializes in utilizing a unique approach that combines digital therapeutics with neuromodulation to enhance cognitive function and address the underlying mechanisms of neurodegeneration. Cognito's research aims to transform the treatment landscape for patients, leveraging advanced technology to improve outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#34 in Newton, MA

#1,546 in Massachusetts

#25,557 in US

#48,163 in the World

Newton, MA, United States of America

Cognito Therapeutics, Inc.

Forward Citations = 124

10 inventors:

Martin Williams (8 out of 10 patents)

Zachary John Hambrecht Malchano (8 out of 8 patents)

Kim Kwan (4 out of 4 patents)

4. Brent Vaughan (4 out of 4 patents)

5. Cory Worth (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cognito Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cognito-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]